Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.564.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.564.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.564.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.564.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.345ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.345ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.345ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.345NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.53ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
B.1.1.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.1.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.1.53NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.450ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.450ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.450ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.450NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.334ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.334ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.334ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.334NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.589ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.589ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.589ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.589NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.335ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.335ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.335ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.335NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.169ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.169ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.169ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.169NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.43ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.43NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.42ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.42ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.42NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AE.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AE.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AE.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.442ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.442ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.442ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.442NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.75ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used